FIDELITY BIOSCIENCES
FIDELITY BIOSCIENCES
Status:
Active
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2014-11-19 | WellAir | Fidelity Biosciences investment in Venture Round - WellAir | 10 M USD |
| 2014-11-12 | Blueprint Medicines | Fidelity Biosciences investment in Series C - Blueprint Medicines | 50 M USD |
| 2014-06-23 | Dimension Therapeutics | Fidelity Biosciences investment in Series A - Dimension Therapeutics | 30 M USD |
| 2014-01-07 | Blueprint Medicines | Fidelity Biosciences investment in Series B - Blueprint Medicines | 25 M USD |
| 2010-05-20 | NeuroTherapeutics Pharma | Fidelity Biosciences investment in Series B - NeuroTherapeutics Pharma | 43 M USD |
| 2006-05-01 | Cardiokine | Fidelity Biosciences investment in Series B - Cardiokine | 50 M USD |
More informations about "Fidelity Biosciences"
Fidelity Bio thinks global with a new partner and a new name: F …
Oct 5, 2015 Fidelity Biosciences, a big venture backer of dozens of global biotech companies, is tying up with Devonshire Capital--which once was called Fidelity Capital--and changing its …See details»
Fidelity Biosciences - Crunchbase Investor Profile & Investments
Dimension Therapeutics raised $30,000,000 / Series A from Fidelity Biosciences and OrbiMed. Discover more funding rounds . Funding Round ...See details»
Fidelity Biosciences Company Profile | Cambridge, MA
Find company research, competitor information, contact details & financial data for Fidelity Biosciences of Cambridge, MA. Get the latest business insights from Dun & Bradstreet.See details»
F-Prime Capital - CB Insights
Jan 31, 2025 F-Prime Capital, formerly Fidelity Biosciences and Devonshire Investors, is a global venture capital firm investing in life sciences, healthcare and technology. Since 1969, F …See details»
Fidelity Biosciences Backs Blueprint Medicines - Venture Capital …
May 24, 2012 About Fidelity Biosciences . Fidelity Biosciences is a subsidiary of FMR LLC, the parent company of Fidelity Investments, one of the world’s leading providers of financial …See details»
Fidelity Biosciences - Investments, Portfolio & Company Exits
Nov 12, 2014 Fidelity Biosciences 's most notable exits include Blueprint Medicines, ... Which industries has this organization had the most exits in? Show . Blueprint Medicines Blueprint …See details»
Fidelity Biosciences - VentureRadar
Fidelity Biosciences invests venture capital in private biopharmaceutical, medical technology, and healthcare IT and services companies. We are engaged investors and board members, …See details»
F-Prime Capital - Crunchbase Investor Profile
F-Prime's roots are in one of America’s great entrepreneurial success stories. Fidelity Investments was founded in 1946 and grew from a single mutual fund into one of the largest asset management firms in the world, with over $2 trillion in …See details»
Fidelity Biosciences - Drug pipelines, Patents, Clinical trials - Synapse
Explore Fidelity Biosciences with its drug pipeline, therapeutic area, technology platform, 1 news. Biomedical products. Data. Feature. Plans. Sign Up for Free. Request Demo. Sign Up for …See details»
Fidelity Select Biotechnology Fund Stock Price - Morningstar
FBIOX - Fidelity Select Biotechnology - Review the FBIOX stock price, growth, performance, sustainability and more to help you make the best investments.See details»
Fidelity Biosciences – Investors Database - Unicorn Nest
Fidelity Biosciences. SAVE. Total investments. 6. Average round size. 34M. Portfolio companies. 5. Follow on index. 0.17. Exits. 3. Areas of investment Biotechnology Health Care Wellness …See details»
Fidelity Biosciences | MyCapital
Fidelity Biosciences invests venture capital in private biopharmaceutical and medical technology companies. We are a division of Fidelity Investments, one of the world’s leading providers of …See details»
F-Prime’s Ketan Patel on ‘reverse ageism’ in biotech and investing …
Jun 30, 2023 Patel has been a part of that firm, first known as Fidelity Biosciences and now F-Prime, ever since. Over that time, he’s invested in and sat on the boards of more than a dozen …See details»
Fidelity bankrolls gene therapy startup with sights on hemophilia
Oct 31, 2013 Fidelity Biosciences is placing a big bet on gene therapy, funding the launch of startup Dimension Therapeutics with some licensed patents and a plan to develop novel …See details»
FBIOX - Fidelity ® Select Biotechnology Portfolio - Fidelity …
Analyze the Fund Fidelity ® Select Biotechnology Portfolio having Symbol FBIOX for type mutual-funds and perform research on other mutual funds. Learn more about mutual funds at …See details»
Board of Directors - docwatsonshealthstuff.com
He joined Fidelity BioSciences, a healthcare venture firm owned by Fidelity, in 2003 as President and Managing Partner. He has worked in the pharmaceutical and biotechnology industries for …See details»
Fidelity® Select Biotechnology Portfolio (FBIOX) Holdings - U.S.
Apr 30, 2017 See holdings data for Fidelity® Select Biotechnology Portfolio (FBIOX). Research information including asset allocation, sector weightings and top holdings for Fidelity® Select …See details»
BioCentury - Planting Fidelity's seeds
May 18, 2015 Fidelity Biosciences Research Initiative has helped create a neurodegenerative disease company that could serve as a repository for the discoveries stemming from seed …See details»
FBIOX Holdings List - Fidelity Select Biotechnology Portfolio
Feb 28, 2025 A list of holdings for FBIOX (Fidelity Select Biotechnology Portfolio) with details about each stock and its percentage weighting in the fund. Skip to main content. Log In Create …See details»
Brett Cook - Partner @ F-Prime Capital - Crunchbase
Brett Cook joined Fidelity Biosciences in 2013. Prior to Fidelity Biosciences, he was a Business Analyst at McKinsey & Company. At McKinsey, he advised hospital & health systems, …See details»